Advertisement
Case Report| Volume 38, ISSUE 6, P581-584, June 2016

Download started.

Ok

A splicing mutation of proteolipid protein 1 in Pelizaeus-Merzbacher disease

  • Taku Omata
    Affiliations
    Division of Child Neurology, Chiba Children’s Hospital, Chiba, Japan
    Search for articles by this author
  • Jun-ichi Nagai
    Affiliations
    Laboratory Medicine, Clinical Research Institute, Kanagawa Children’s Medical Center, Yokohama 232-855, Japan
    Search for articles by this author
  • Hiroko Shimbo
    Affiliations
    Division of Neurology, Clinical Research Institute, Kanagawa Children’s Medical Center, Yokohama 232-855, Japan
    Search for articles by this author
  • Shiro Koizume
    Affiliations
    Division of Neurology, Clinical Research Institute, Kanagawa Children’s Medical Center, Yokohama 232-855, Japan

    Division of Genetics, Clinical Research Institute, Kanagawa Children’s Medical Center, Yokohama 232-855, Japan

    Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama 241-0815, Japan
    Search for articles by this author
  • Yohei Miyagi
    Affiliations
    Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama 241-0815, Japan
    Search for articles by this author
  • Kenji Kurosawa
    Affiliations
    Division of Genetics, Clinical Research Institute, Kanagawa Children’s Medical Center, Yokohama 232-855, Japan
    Search for articles by this author
  • Sumimasa Yamashita
    Affiliations
    Division of Neurology, Clinical Research Institute, Kanagawa Children’s Medical Center, Yokohama 232-855, Japan
    Search for articles by this author
  • Hitoshi Osaka
    Correspondence
    Corresponding author at: Department of Pediatrics, Jichi Medical School, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi 329-0498, Japan. Tel.: +81 285 58 7366; fax: +81 285 44 6123.
    Affiliations
    Division of Neurology, Clinical Research Institute, Kanagawa Children’s Medical Center, Yokohama 232-855, Japan

    Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama 241-0815, Japan

    Department of Pediatrics, Jichi Medical School, Shimono, Japan
    Search for articles by this author
  • Ken Inoue
    Affiliations
    Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan
    Search for articles by this author
Published:December 22, 2015DOI:https://doi.org/10.1016/j.braindev.2015.12.002

      Abstract

      A patient with an unusually mild form of Pelizaeus-Merzbacher disease was studied. Clinically, mild developmental delay with acquisition of assisted walking at 16 months and mild spastic tetraplegia were evident, but no nystagmus, cerebellar, or extra-pyramidal signs were present. PLP1 mutation analysis revealed a nucleotide substitution adjacent to the acceptor site of intron 3, NM_000533.4:c.454-9T>G. Expression analysis using the patient’s leukocytes demonstrated an additional abnormal transcript including the last 118 bp of intron 3. In silico prediction analysis suggested the reduction of wild-type acceptor activity, which presumably evokes the cryptic splicing variant. Putative cryptic transcript results in premature termination, which may explain the mild clinical phenotype observed in this patient.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Inoue K.
        PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
        Neurogenetics. 2005; 6: 1-16
        • Bonnet-Dupeyron M.N.
        • Combes P.
        • Santander P.
        • Cailloux F.
        • Boespflug-Tanguy O.
        • Vaurs-Barriere C.
        PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
        Hum Mutat. 2008; 29: 1028-1036
        • Hobson G.M.
        • Davis A.P.
        • Stowell N.C.
        • Kolodny E.H.
        • Sistermans E.A.
        • de Coo I.F.
        • et al.
        Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease.
        Neurology. 2000; 55: 1089-1096
        • Osaka H.
        • Kawanishi C.
        • Inoue K.
        • Onishi H.
        • Kobayashi T.
        • Sugiyama N.
        • et al.
        Pelizaeus-Merzbacher disease: three novel mutations and implication for locus heterogeneity.
        Ann Neurol. 1999; 45: 59-64
        • Reese M.G.
        • Eeckman F.H.
        • Kulp D.
        • Haussler D.
        Improved splice site detection in Genie.
        J Comput Biol. 1997; 4: 311-323
        • Desmet F.O.
        • Hamroun D.
        • Lalande M.
        • Collod-Beroud G.
        • Claustres M.
        • Beroud C.
        Human Splicing Finder: an online bioinformatics tool to predict splicing signals.
        Nucleic Acids Res. 2009; 37: e67
        • Yeo G.
        • Burge C.B.
        Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals.
        J Comput Biol. 2004; 11: 377-394
        • Wang M.
        • Marin A.
        Characterization and prediction of alternative splice sites.
        Gene. 2006; 366: 219-227
        • Cailloux F.
        • Gauthier-Barichard F.
        • Mimault C.
        • Isabelle V.
        • Courtois V.
        • Giraud G.
        • et al.
        Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations.
        Eur J Hum Genet. 2000; 8: 837-845
        • Stenson P.D.
        • Mort M.
        • Ball E.V.
        • Shaw K.
        • Phillips A.
        • Cooper D.N.
        The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine.
        Hum Genet. 2014; 133: 1-9